期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

新型钙通道阻滞药依福地平

Efonidipine:a novel calcium channel blocker
原文传递
导出
摘要 依福地平是一个新型的钙通道阻滞药,具有同时阻滞L型钙通道和T型钙通道的作用。除治疗高血压外,依福地平尚在延迟慢性肾脏疾病进展、治疗心力衰竭、延迟心房颤动电生理重构、预防肺静脉触发活动中发挥重要作用。 Efonidipine is a novel calcium channel blocker, and has the function of blocking both L type and T type calcium channel. In addition to the treatment of hypertension, efonidipine has the important function in delaying chronic kidney disease, treating heart failure, delaying electrical remodeling of atrial fibrillation and preventing triggered activity of the pulmonary vein.
作者 黄震华
机构地区 上海交通大学医学院附属第九人民医院心血管病研究室
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2010年第7期481-484,共4页 Chinese Journal of New Drugs and Clinical Remedies
关键词 高血压 心力衰竭 充血性 心房颤动 钙通道阻滞药 依福地平 hypertension heart failure, congestive atrial fibrillation calcium channel blockers efonidipine
分类号 R969.4 [医药卫生—药理学] R972 [医药卫生—药品]
  • 相关文献

参考文献20

  • 1DAHLOF B, SEVER PS, POULTER NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOTBPLA) : a multicentre randomized controlled trial [J]. Lancet, 2005, 366(9489) : 895-906.
  • 2CATTERALL WA, GOLDIN AL, WAXMAN SG. International Union of Pharmacology XL VII: nomenclature and structurefunction relationships of voltage-gated sodium channels [J]. Pharmacol Rev, 2005, 57(4): 397-409.
  • 3ONO K, IIJIMA T. Pathophysiological significance of T-type Ca^2+ channels: proterties and functional role of T-type Ca^2+ channels in cardiac pacemaking[J]. J Pharmacol Sei, 2005, 99 (3): 197-204.
  • 4MANGONI ME, TRABOULSIE A, LEONI AL, et al. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha 1G T-type calcium channels[J]. Circ Res, 2006, 98 ( 11 ) : 1422-1430.
  • 5LEE TS, KAKU T, TAKEBAYASHI S, et al. Actions of mibefradil, efonidipine and nifedipine block of recombinant T-and L-type Ca channels with distinct inhibitory mechanisms [J]. Pharmacology, 2006, 78 ( 1 ) : 11-20.
  • 6OHASHI N, MITAMURA H, OGAWA S. Development of newer calcium channel antagonists. Therapeutic potential of efonidipine in preventing electrical remodeling during atrial fibrillation[J]. Dugs, 2009, 69 ( 1 ) : 21-20.
  • 7FURUKAWA T, MIURA R, HONDA M, et al. Identification of R (-)-isomer of efonidipine as a selective blocker of T-type Ca^2+ channels[J]. Br J Pharmacol, 2004, 143(8) : 1050-1057.
  • 8TANAKA H, KOMIKADO C, SHIMADA H, et al. The R(-)- enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium[J]. J Pharmacol Sci, 2004, 96(4): 499-501.
  • 9SUGANO N, WAKINO S, KANDA T, et al. T-type calcium channel blockade as a therapeutie strategy against renal injury in rats with subtotal nephrectomy[J]. Kidney Int, 2008, 73 (7): 826-834.
  • 10JATOS Study Group. The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS): protocol, patient characteristics, and blood pressure daring the first 12 months[J]. Hypertens Res, 2005, 28(6): 513-520.
中国新药与临床杂志
2010年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部